CN Patent

CN112969458A — 血浆激肽释放酶抑制剂的结晶盐

Assigned to Biocryst Pharmaceuticals Inc · Expires 2021-06-15 · 5y expired

What this patent protects

公开了化合物I的结晶盐、其制备方法及其相关药物制剂。还公开了使用本发明的结晶盐进行治疗的方法。

USPTO Abstract

公开了化合物I的结晶盐、其制备方法及其相关药物制剂。还公开了使用本发明的结晶盐进行治疗的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN112969458A
Jurisdiction: CN
Classification: —
Expires: 2021-06-15
Drug substance claim: No
Drug product claim: No
Assignee: Biocryst Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.